Root Financial Partners’s Ginkgo Bioworks DNA Stock Holding History

Root Financial Partners’s Portfolio DNA Stock Details DNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$147	Buy	+24	New	+$200	﹤0.01%	3215

Other funds holding DNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

ACG

Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JMFC

J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Root Financial Partners's DNA Position: Q1 2026 in Review

Root Financial Partners opened a new position in Ginkgo Bioworks (DNA) in Q1 2026: 24 shares worth $147. The stake represents ﹤0.01% of the portfolio and ranks #3215 among its holdings.

174 funds tracked by Wall St. Rank hold DNA as of Q1 2026.

Root Financial Partners held 24 shares of Ginkgo Bioworks worth $147 as of Q1 2026.
Ginkgo Bioworks was a new Root Financial Partners position in Q1 2026.
Ginkgo Bioworks made up ﹤0.01% of Root Financial Partners's portfolio in Q1 2026, its #3215 holding.
174 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q1 2026.

Based on Root Financial Partners's 13F filing for Q1 2026, filed 24 Apr 2026.